- Home
- VMAR vs XRTX Comparison
VMAR vs XRTX Comparison
Compare VMAR & XRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VMAR
- XRTX
- Stock Information
- Founded
- VMAR 1995
- XRTX 2011
- Country
- VMAR Canada
- XRTX Canada
- Employees
- VMAR N/A
- XRTX N/A
- Industry
- VMAR Marine Transportation
- XRTX Pharmaceuticals and Biotechnology
- Sector
- VMAR Industrials
- XRTX Health Care
- Exchange
- VMAR Nasdaq
- XRTX Nasdaq
- Market Cap
- VMAR 5.1M
- XRTX 4.2M
- IPO Year
- VMAR 2020
- XRTX N/A
- Fundamental
- Price
- VMAR $7.74
- XRTX $0.92
- Analyst Decision
- VMAR Strong Buy
- XRTX
- Analyst Count
- VMAR 1
- XRTX 0
- Target Price
- VMAR $2,700.00
- XRTX N/A
- AVG Volume (30 Days)
- VMAR 33.1K
- XRTX 29.0K
- Earning Date
- VMAR 07-14-2025
- XRTX 08-13-2025
- Dividend Yield
- VMAR N/A
- XRTX N/A
- EPS Growth
- VMAR N/A
- XRTX N/A
- EPS
- VMAR N/A
- XRTX N/A
- Revenue
- VMAR $1,612,492.00
- XRTX N/A
- Revenue This Year
- VMAR N/A
- XRTX N/A
- Revenue Next Year
- VMAR $264.29
- XRTX N/A
- P/E Ratio
- VMAR N/A
- XRTX N/A
- Revenue Growth
- VMAR N/A
- XRTX N/A
- 52 Week Low
- VMAR $4.04
- XRTX $0.80
- 52 Week High
- VMAR $783.00
- XRTX $2.98
- Technical
- Relative Strength Index (RSI)
- VMAR 53.38
- XRTX 39.98
- Support Level
- VMAR $6.23
- XRTX $0.80
- Resistance Level
- VMAR $8.13
- XRTX $0.88
- Average True Range (ATR)
- VMAR 0.66
- XRTX 0.05
- MACD
- VMAR -0.11
- XRTX -0.00
- Stochastic Oscillator
- VMAR 59.22
- XRTX 24.20
About VMAR Vision Marine Technologies Inc.
Vision Marine Technologies Inc is in the business of designing and manufacturing electric outboard powertrain systems, power boats, and related technology and the renting of electric boats. The different models of the powerboats and electric boats manufactured by the company include Bruce 22, Fantail 217, Volt 180, and others. The company operates in two reportable business segments; Sale of electric boats and Rental of electric boats. The majority of the revenue for the company is generated from the Sale of electric boats segment. Geographically, the company generates revenue from its business in Canada, USA and other countries. A substantial portion of the overall revenue is generated from its business in USA.
About XRTX XORTX Therapeutics Inc.
XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.